Joe Braunwart

Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

Timothy E Hewett, T. Hewett, J. Molkentin, 2003, The Journal of clinical investigation.

05 Inhibition of p38 mitogen-activated protein kinase (MAPK) leads to hypertrophic cardiomyopathy

J. Molkentin, O. Bueno, B. Wilkins, 2002 .